XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities      
Net income $ 114 $ 62 $ 33
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 100 116 134
Stock-based compensation expense 119 126 126
Deferred income taxes (11) (11) (26)
Loss on Blue Chip Swap 4 13 0
Changes in assets and liabilities:      
Receivables 52 78 (28)
Inventories (5) (5) 18
Account payables and accrued expenses (1) 7 35
Deferred revenue (70) (5) 18
Other assets and liabilities 1 (6) 109
Net cash provided by operating activities 303 375 419
Investing activities      
Expenditures for property and equipment (24) (19) (14)
Additions to capitalized software (2) (1) (2)
Business acquisitions, other investing activities and proceeds on Blue Chip Swap, net of purchases (6) (29) (2)
Net cash used in investing activities (32) (49) (18)
Financing activities      
Repurchases of common stock (215) (308) (387)
Proceeds from long-term borrowings 0 0 500
Repayments of long-term borrowings (19) 0 (413)
Payments of finance leases (71) (82) (86)
Other financing activities, net (1) 7 5
Net cash used in financing activities (306) (383) (381)
Effect of exchange rate changes on cash and cash equivalents (30) (28) (44)
Decrease in cash, cash equivalents and restricted cash (65) (85) (24)
Cash, cash equivalents and restricted cash at beginning of year 486 571 595
Cash, cash equivalents and restricted cash at end of year 421 486 571
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets      
Cash and cash equivalents 420 486 569
Restricted cash 1 0 2
Total cash, cash equivalents and restricted cash 421 486 571
Supplemental cash flow disclosure:      
Assets acquired by finance lease 29 90 78
Assets acquired by operating lease 5 6 4
Cash paid during the year for:      
Income taxes, net 75 65 (18)
Interest $ 29 $ 30 $ 23